Robin Lytle is currently the Associate Director at Takeda, where they lead a team in DNA Construct Design and Cell Line Generation for various therapeutic programs. Previously, Robin served as a Research Principal Scientist at Takeda and held roles at EMD Serono, Immucor, Inc., and Yale University, contributing significantly to biopharmaceutical research and development. Robin's academic journey includes ongoing Ph.D. studies in Biochemistry/Molecular Biology at Weill Medical College of Cornell University and a Bachelor of Science in Biochemistry from Clemson University. Robin's innovative work has led to patent recognition and multiple advancements in cell line generation technologies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices